Zimmer Biomet Holdings, Inc.
ZBH
$100.91
$1.431.44%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 4.33% | -7.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.33% | -7.00% | |||
| Cost of Revenue | 12.64% | -29.08% | |||
| Gross Profit | 1.25% | 5.12% | |||
| SG&A Expenses | 4.27% | 0.92% | |||
| Depreciation & Amortization | 0.80% | -8.78% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.57% | -13.18% | |||
| Operating Income | -4.82% | 31.08% | |||
| Income Before Tax | -15.33% | 207.76% | |||
| Income Tax Expenses | -11.90% | 257.89% | |||
| Earnings from Continuing Operations | -16.24% | 72.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -550.00% | -113.33% | |||
| Net Income | -16.72% | 70.93% | |||
| EBIT | -4.82% | 31.08% | |||
| EBITDA | -2.79% | 13.96% | |||
| EPS Basic | -15.50% | 72.85% | |||
| Normalized Basic EPS | -4.87% | 36.19% | |||
| EPS Diluted | -15.57% | 72.71% | |||
| Normalized Diluted EPS | -4.77% | 36.24% | |||
| Average Basic Shares Outstanding | -1.44% | -1.12% | |||
| Average Diluted Shares Outstanding | -1.53% | -1.16% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.19% | -0.42% | |||